Paper trail

January 2024

The five widest Discovery Gaps at the end of January 2024, revisited today from the same public filings. Descriptive, not predictive.

NEXT—NextDecade Corp

All industries

Then · 31 Jan 2024
Discovery Gap Very high (100/100)·AIR Weak (40/100)
Now · 21 Nov 2026
Discovery Gap Very high (79/100)·AIR Weak (35/100)·Left the top 5

Since then: Management change (29 Sep 2026)·Commercial traction (2 Jul 2026)·Catalyst (2 Jul 2026)·Catalyst (17 Jun 2026)·Commercial traction (17 Jun 2026)·Management change (3 Jun 2026)

IE—Ivanhoe Electric Inc.

All industries

Then · 31 Jan 2024
Discovery Gap Very high (97/100)·AIR Weak (40/100)
Now · 21 Nov 2026
Discovery Gap Very high (68/100)·AIR High risk (30/100)·Left the top 5

Since then: Catalyst (19 Nov 2026)·Catalyst (23 Sep 2026)·Management change (3 Aug 2026)·Commercial traction (7 Jul 2026)·Commercial traction (28 May 2026)·Management change (20 May 2026)

RXRX—RECURSION PHARMACEUTICALS, INC.

Biotech

Then · 31 Jan 2024
Discovery Gap Very high (94/100)·AIR Neutral (54/100)
Now · 21 Nov 2026
Discovery Gap Very high (70/100)·AIR Cautious (45/100)·Left the top 5

Since then: Catalyst (31 Oct 2026)·Management change (31 Oct 2026)·Commercial traction (15 Oct 2026)·Catalyst (15 Oct 2026)·Catalyst (15 Oct 2026)·Commercial traction (15 Sep 2026)

PHAT—Phathom Pharmaceuticals, Inc.

Biotech

Then · 31 Jan 2024
Discovery Gap Very high (94/100)·AIR Cautious (45/100)
Now · 21 Nov 2026
Discovery Gap Low (3/100)·AIR Cautious (40/100)·Left the top 5

Since then: Management change (12 Nov 2026)·Catalyst (29 Oct 2026)·Catalyst (26 Oct 2026)·Catalyst (23 Oct 2026)·Catalyst (29 Sep 2026)·Catalyst (30 Jul 2026)

TLRY—Tilray Brands, Inc.

Biotech

Then · 31 Jan 2024
Discovery Gap Very high (94/100)·AIR Cautious (45/100)
Now · 21 Nov 2026
Discovery Gap Low (0/100)·AIR Neutral (54/100)·Left the top 5

Since then: Catalyst (8 Oct 2026)·Catalyst (8 Sep 2026)·Catalyst (4 Aug 2026)·Catalyst (28 Jul 2026)·Catalyst (24 Jun 2026)·Catalyst (3 Jun 2026)